Skip to content

The effect of cervical transcutaneous electrical neurostimulation on cerebral blood flow and infarction as a result of vasospasm after subarachnoid haemorrhage.

The effect of cervical transcutaneous electrical neurostimulation on cerebral blood flow velocities, cerebral vasospasm and ischemic deficit in secondary cerebral vasospasm after subarachnoid haemorrhage.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON21953
Enrollment
10
Registered
2010-06-05
Start date
2010-07-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subarachnoid haemorrhage (SAH), cerebral vasospasm, transcutaneous electrical neurostimulation (TENS), sympathetic nervous system. Subarachnoidale bloeding (SAB), cerebrale vaatspasmen, transcutane electrische neurostimulatie (TENS), sympathisch zenuwstelsel.

Interventions

The first part of the study concerns the finding of an optimal frequency. When the stimulation will be started, optimal parameters will be sought. The pulse-width will be 200ms in all patients. The cu

Sponsors

University Medical Center Groningen, Departments of neurosurgery, clinical neurophysiology, neurology and epidemiology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Confirmed aneurysmatic subarachnoid hemorrhage; 2. Cerebral vasospasm demonstrated by TCD, defined as a MCA/ICA ratio >3; 3. Aneurysm is treated with a surgical or endovascular procedure; 4. Age > 18 years; 5. Treatment can be started promptly; 6. Informed consent signed by patient or family.

Exclusion criteria

Exclusion criteria: 1. History of cervical spine or skull-base surgery; 2. Known adverse reaction to TENS-pads; 3. The presence of any implanted electronic device (including pacemakers); 4. Pre-existing disease that can obscure follow-up; 5. Unacceptable interference with cardiographic registration (in case intensive care is necessary); 6. Insuficient temporal bony windows.

Design outcomes

Primary

MeasureTime frame
Cerebral bloodflowvelocities as measured with TCD.

Secondary

MeasureTime frame
1. Cerebral oxygenation determined by NIRS; 2. Neurological examination, combined with CT image; 3. Bloodpressure and pulse; 4. Registration of adverse events.

Contacts

Public ContactM. Laan, ter

Hanzeplein 1, PB 90.001

m.ter.laan@nchir.umcg.nl+31 (0)50 3612440

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)